ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer

Liu, Meng; Sun, Chuanchuan; Jiang, Jiangle; Wan, Li; Hu, Chong; Wen, Chunping; Huang, Guiju; Ruan, Qiufen; Wu, Shuang; Qiao, Dan; Zheng, Pengwu; Pan, Qingshan*; Zhu, Wufu*南昌航空大学
ACS Applied Nano Materials2023-11-18DOI: 10.1021/acsanm.3c03564
11阅读
引用收藏
分享

摘要

The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (GEF) has been used to treat nonsmall-cell lung cancer (NSCLC); yet, the curative effect of GEF was compromised by drug resistance. Herein, an EGFR aptamer-modified therapeutic strategy (Apt/(siRNA + GEF)@ZIF-8 nanoparticles (NPs)) was fabricated by employing zeolitic imidazolate framework-8 (ZIF-8)-based metal-organic frameworks for targeted delivery of GEF and EGFR siRNA to suppress the drug-resistant gene expression in tumors. Apt/(siRNA + GEF)@ZIF-8 NPs had a high loading efficiency for GEF and siRNA, and the particle size was about 75 nm with a stable crystal structure. In vitro experiments showed that GEF cooperating with siRNA could promote cell apoptosis and displayed a synergistic therapeutic effect on drug-resistant cancer cells. In vivo biodistribution study demonstrated that Apt/(siRNA + GEF)@ZIF-8 could be enriched at tumor sites successfully, which provided a basis for in vivo antitumor experiments. In vivo experiment illustrated that the NPs with good biocompatibility had a high efficiency for conquering the acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC with a tumor inhibition rate of 40.6%. Overall, the findings from this study implied that this biological target nanodrug therapy may provide a promising approach for the treatment of drug-resistant NSCLC.

学科与关键词

关键词
NSCLCdrug resistancesmall interfering RNAmetal-organic frameworkscancer therapy
相关
加载中…
  • An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging
    Xie, Xin; Zhan, Chenyue; Wang, Jie; Zeng, Fang*; Wu, Shuizhu*Small, 2020, 16(38): 2003451.被引 22
  • A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy
    Xu, Bin; Zeng, Fanjun; Deng, Jialong; Yao, Lintong; Liu, Shengbo; Hou, Hengliang; Huang, Yucheng; Zhu, Hongyuan; Wu, Shaowei; Li, Qiaxuan; Zhan, Weijie; Qiu, Hongrui; Wang, Huili; Li, Yundong; Yang, Xianzhu; Cao, Ziyang*; Zhang, Yu*; Zhou, Haiyu*Bioactive Materials, 2023, 27: 337-347.被引 5
  • Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
    Diao, Dingwei; Zhai, Jianxue; Yang, Jianjun; Wu, Hua; Jiang, Jianjun; Dong, Xiaoying; Passaro, Antonio; Aramini, Beatrice; Rao, Shuan*; Cai, Kaican*Translational Lung Cancer Research, 2021, 10(2): 926-935.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS Applied Nano Materials
发表日期
2023-11-18
卷期
第 6 卷, 第 23 期
页码
21587-21602
DOI
10.1021/acsanm.3c03564
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22264015, 21964013]; National Natural Science Foundation of China [20232ACB216017]; Outstanding Youth Fund project of the Natural Science Foundation of Jiangxi Province [20224BAB206001, 20224ACB216016, 20224BAB216006]; Natural Science Foundation of Jiangxi, China [GJJ211121, GJJ211132]; Science and Technology Research Project of Jiangxi Education Department [2022QNBJRC003]; Jiangxi University of Science and Technology Research Program of Young Talent [2020BSQD019]; Start-up Fund of Science Research Project of Jiangxi Science and Technology Normal University [JKLDE-KF-2103]; Open Project of Jiangxi Provincial Key Laboratory of Drug Design and Evaluation [20221604117]; Graduate Student Innovation Special Fund Project of Jiangxi Science and Technology Normal University [202211318025, 20220804037, 20220804038]; College Student Innovation and Entrepreneurship Training Program

作者

  • L

    Liu, Meng (第一作者)

    jiangxi sci & technol normal univ

  • S

    Sun, Chuanchuan

    jiangxi sci & technol normal univ

查看全部 13 位作者收起作者
  • J

    Jiang, Jiangle

    jiangxi sci & technol normal univ

  • W

    Wan, Li

    jiangxi sci & technol normal univ

  • H

    Hu, Chong

    jiangxi sci & technol normal univ

  • W

    Wen, Chunping

    jiangxi sci & technol normal univ

  • H

    Huang, Guiju

    jiangxi sci & technol normal univ

  • R

    Ruan, Qiufen

    jiangxi sci & technol normal univ

  • W

    Wu, Shuang

    nanchang hangkong univ

  • Q

    Qiao, Dan

    jiangxi sci & technol normal univ

  • Z

    Zheng, Pengwu

    jiangxi sci & technol normal univ

  • P

    Pan, Qingshan (通讯)

    jiangxi sci & technol normal univ

  • Z

    Zhu, Wufu (通讯)

    jiangxi sci & technol normal univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417